<< Вернуться к списку статей журнала

Том 14 №1 2012 год - Нефрология и диализ

Нефропатический цистиноз: современные представления об этиологии и патогенезе (Обзор литературы)

Каган М.Ю.

Аннотация: Причиной цистиноза является мутация гена CTNS, кодирующего синтез лизосомального переносчика цистина. Накопление цистина внутри лизосом приводит к развитию у большинства пациентов генерализованной дисфункции проксимальных канальцев (синдром де Тони–Дебре–Фанкони ) на первом году жизни и прогрессирующей хронической болезни почек в течение первой декады жизни. После десятилетнего возраста манифестируют клинические проявления, свидетельствующие о повреждении экстраренальных органов. Лечение цистеамином, снижающим внутриклеточную концентрацию цистина, значительно замедляет темпы прогрессирования заболевания, но не оказывает влияние на многие патогенетические механизмы. В этом обзоре обсуждаются новые представления об этиологии и патогенезе данного заболевания.

Для цитирования: Каган М.Ю. Нефропатический цистиноз: современные представления об этиологии и патогенезе (Обзор литературы). Нефрология и диализ. 2012. 14(1):015-022. doi:

Весь текст

Ключевые слова: транспорт цистина, синдром Фанкони, глютатион, cystine transport, Fanconi syndrome, glutathione

Список литературы:

1. Abderhalden E. Familiare cystindiathese // Hopp. Seylers Zeitschr. Physiol. Chemie. 1903. Vol. 38. P. 557–561.
2. Alcántara-Ortigoza M.A., Belmont-Martínez L., Vela-Amieva M., González-Del Angel A. Analysis of the CTNS gene in nephropathic cystinosis Mexican patients: report of four novel mutations and identification of a false positive 57-kb deletion genotype with LDM-2/exon 4 multiplex PCR assay // Genet. Test. 2008. Vol. 12 (3). P. 409–414.
3. Anikster Y., Shotelersuk V., Gahl W.A. CTNS mutations in patients with cystinosis // Hum. Mutat. 1999. Vol. 14 (6). P. 454–458.
4. Attard M., Jean G., Forestier L. et al. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin // Hum. Mol. Genet. 1999. Vol. 8 (13). P. 2507–2514.
5. Bellomo F., Corallini S., Pastore A. et al. Modulation of CTNS gene expression by intracellular thiols // Free Radic. Biol. Med. 2010. Vol. 48 (7). P. 865–872.
6. Bennun A., Bashan N., Potashnik R., Cohenluria R., Moran A. Cystine dimethyl ester reduces the forces driving sodium-dependent transport in LLC-PK1 cells // Am. J. Physiol. Cell Physiol. 1992. Vol. 263. C516–C520.
7. Bens M., Vandewalle A. Cell models for studying renal physiology // Pflugers Arch. 2008. Vol. 457 (1). P. 1–15.
8. Chabli A., Aupetit J., Raehm M. et al. Measurement of cystine in granulocytes using liquid chromatography-tandem mass spectrometry // Clin. Biochem. 2007. Vol. 40 (9–10). P. 692–698.
9. Cherqui S., Sevin C., Hamard G. et al. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis // Mol. Cell. Biol. 2002. Vol. 22 (21). P. 7622–7632.
10. Chevalier R.L., Forbes M.S. Generation and evolution of atubular glomeruli in the progression of renal disorders // J. Am. Soc. Nephrol. 2008. Vol. 19 (2). P. 197–206.
11. Chol M, Nevo N, Cherqui S, Antignac C, Rustin P. Glutathione precursors replenish decreased glutathione pool in cystinotic cell lines // Biochem. Biophys. Res. Commun. 2004. Vol. 324 (1). P. 231–235.
12. Coor C., Salmon R.F., Quigley R., Marver D., Baum M. Role of adenosine triphosphate (ATP) and NaK ATPase in the inhibition of proximal tubule transport with intracellular cystine loading // J. Clin. Invest. 1991. Vol. 87 (3). P. 955–961.
13. Danpure C.J., Jennings P.R., Fyfe D.A. Further studies on the effect of chloroquine on the uptake, metabolism and intracellular translocation of [35S].cystine in cystinotic fibroblasts // Biochim. Biophys. Acta. 1986. Vol. 885 (3). P. 256–265.
14. De Toni G. Remarks on the relations between renal rickets (renal dwarfism) and renal diabetes // Acta Paediatrica. 1933. Vol. 16. P. 479–484.
15. Debre R., Marie J., Cleret J., Messimy R. Rachitisme tardif coexistant avrc une nephrite chronique et une glycosurie // Arch. Med. Enfants. 1934. Vol. 37. P. 597–606.
16. Detrisac C.J., Mayfield R.K., Colwell J.A. et al. In vitro culture of cells exfoliated in the urine by patients with diabetes mellitus // J. Clin. Invest. 1983. Vol. 71 (1). P. 170–173.
17. Diomedi-Camassei F., Di Giandomenico S., Santorelli F.M. et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement // J. Am. Soc. Nephrol. 2007. Vol. 18 (10). P. 2773–2780.
18. Evers R., Zaman G.J., van Deemter L. Et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells // J. Clin. Invest. 1996. № 1. Vol. 97 (5). P. 1211–1218.
19. Fanconi G. Die nicht diabetischen glykosurien und hyperglykamiendes altem kindes // Jahrbuch Kinderheilkunde. 1931. Vol. 133. P. 257–300.
20. Fernández E., Torrents D., Chillarón J., Martín Del Río R., Zorzano A., Palacín M. Basolateral LAT-2 has a major role in the transepithelial flux of L-cystine in the renal proximal tubule cell line OK // J. Am. Soc. Nephrol. 2003. Vol. 14 (4). P. 837–847.
21. Fernandez-Valero E M., Ballart A., Iturriaga C. et al. Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations // Clin. Genet. 2005. Vol. 68 (3). P. 245–254.
22. Foreman JW, Bowring MA, Lee J, States B, Segal S. Effect of cystine dimethylester on renal solute handling and isolated renal tubule transport in the rat: a new model of the Fanconi syndrome // Metabolism. 1987. Vol. 36 (12). P. 1185–1191.
23. Forestier L., Jean G., Attard M. et al. Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay // Am. J. Hum. Genet. 1999. Vol. 65 (2). P. 353–359.
24. Franco R., Cidlowski J.A. SLCO/OATP-like transport of glutathione in FasL-induced apoptosis: glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis // J. Biol. Chem. 2006. Vol. 281 (40). P. 29542–29557.
25. Frey I.M., Rubio-Aliaga I., Siewert A. et al. Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice // Physiol. Genomics. 2007. Vol. 12. 28 (3). P. 301–310.
26. Gahl WA, Balog JZ, Kleta R. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy // Ann. Intern. Med. 2007. Vol. 21. 147 (4). P. 242–250.
27. Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis // Science. 1982. Vol. 24. 217 (4566). P. 1263–1265.
28. Gahl W.A., Thoene J.G., Schneider J.A. Cystinosis: a disorder of lysosomal membrane transport / In The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. New York: McGraw-Hill, 2001. P. 5085–6108.
29. Gahl W.A., Tietze F., Bashan N. et al. Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes // J. Biol. Chem. 1982. Vol. 25. 257 (16). P. 9570–9575.
30. Gahl W.A., Tietze F., Butler J.D., Schulman J.D. Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange // Biochem. J. 1985. Vol. 15. 228 (3). P. 545–550.
31. Gibson A., Futter C.E., Maxwell S. et al. Sorting mechanisms regulating membrane protein traffic in the apical transcytotic pathway of polarized MDCK cells // J. Cell. Biol. 1998. Vol. 5. 143 (1). P. 81–94.
32. Goldman H., Scriver C.R., Aaron K., Pinsky L. Use of dithiothreitol to correct cystine storage in cultured cystinotic fibroblasts // Lancet. 1970. Vol. 1 (7651). P. 811–812.
33. Goldman R., Kaplan A. Rupture of rat liver lysosomes mediated by L-amino acid esters // Biochim. Biophys. Acta. 1973. Vol. 318 (2). P. 205–216.
34. Graaf-Hess A., Trijbels F., Blom H. New method for determining cystine in leukocytes and fibroblasts // Clin. Chem. 1999. Vol. 45 (12). P. 2224–2228.
35. Hall A.M., Unwin R.J. The not so «mighty chondrion»: emergence of renal diseases due to mitochondrial dysfunction // Nephron Physiol. 2007. Vol. 105 (1). P. 1–10.
36. Hintz D.S., Sens M.A., Jenkins M.Q., Sens D.A. Tissue culture of epithelial cells from urine. I. Serum-free growth of cells from newborn infants // Pediatr. Pathol. 1984. Vol. 2 (2). P. 153–163.
37. Hippert C., Dubois G., Morin C. et al. Gene transfer may be preventive but not curative for a lysosomal transport disorder // Mol. Ther. 2008. Vol. 16 (8). P. 1372–1381.
38. Jackson J.D., Smith F.G., Litman N.N., Yuile C.L., Latta H. The Fanconi syndrome with cystinossis. Electron microscopy of renal biopsy specimens from five patients // Am. J. Med. 1962. Vol. 33. P. 893–910.
39. Jonas A.J., Smith M.L., Allison W.S. et al. Proton-translocating ATPase and lysosomal cystine transport // J. Biol. Chem. 1983. Vol. 10. 258 (19). P. 11727–11730.
40. Jonas A.J., Smith M.L., Schneider J.A. ATP-dependent lysosomal cystine efflux is defective in cystinosis // J. Biol. Chem. 1982. Vol. 25. 257 (22). P. 13185–13188.
41. Kalatzis V., Cherqui S., Antignac C., Gasnier B. Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter // EMBO J. 2001. Vol. 20 (21). P. 5940–5949.
42. Kalatzis V., Nevo N., Cherqui S., Gasnier B., Antignac C. Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin // Hum. Mol. Genet. 2004. Vol. 13 (13). P. 1361–1371.
43. Kalatzis V., Serratrice N., Hippert C. et al. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis // Pediatr. Res. 2007. Vol. 62 (2). P. 156–162.
44. Kirlin W.G., Cai J., Thompson S.A., Diaz D., Kavanagh T.J., Jones D.P. Glutathione redox potential in response to differentiation and enzyme inducers // Free Radic. Biol. Med. 1999. Vol. 27 (11–12). P. 1208–1218.
45. Kroll W.A., Schneider J.A. Decrease in free cystine content of cultured cystinotic fibroblasts by ascorbic acid // Science. 1974. Vol. 186 (4168). P. 1040–1042.
46. Laube GF, Shah V, Stewart VC et al. Glutathione depletion and increased apoptosis rate in human cystinotic proximal tubular cells // Pediatr. Nephrol. 2006. Vol. 21 (4). P. 503–509.
47. Levtchenko E.N., de Graaf-Hess A., Blom H.J., Monnens L.A. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome // Clin. Nephrol. 2002. Vol. 57 (5). P. 349–351.
48. Levtchenko E.N., Wilmer M.J., Kluijtmans L.A., Monnens L.A., Van der Heuvel L.P. Cysteamin treatment in cystinotic proximal tubular cells increases intracellular glutathione without restoring decreased ATP levels (Abstract) // J. Am. Soc. Nephrol. 2009. Vol. 20. P. 283A.
49. Lignac G. Ueber Storung des Cystinstoffwechsels bei Kindern // Deut. Arch. Klin. Med. 1924. Vol. 145. P. 139–150.
50. Luzio J.P., Pryor P.R., Bright N.A. Lysosomes: fusion and function // Nat. Rev. Mol. Cell. Biol. 2007. Vol. 8 (8). P. 622–632.
51. Mahoney C.P., Striker G.E. Early development of the renal lesions in infantile cystinosis // Pediatr. Nephrol. 2000. Vol. 15 (1–2). P. 50–56.
52. Mannucci L., Pastore A., Rizzo C. et al. Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblasts // Pediatr. Res. 2006. Vol. 59 (2). P. 332–335.
53. Markovich D., Verri T., Sorribas V. et al. Regulation of opossum kidney (OK) cell Na/Pi cotransport by Pi deprivation involves mRNA stability // Pflugers Arch. 1995. Vol. 430 (4). P. 459–463.
54. Medlar A., Kleta R. Cystinosis and mickey mouse // Nephrol. Dial. Transplant. 2010. Vol. 25 (4). P. 1032–1033.
55. Miyauchi S., Gopal E., Babu E. et al. Sodium-coupled electrogenic transport of pyroglutamate (5-oxoproline) via SLC5A8, a monocarboxylate transporter // Biochim. Biophys. Acta. 2010. Vol. 1798 (6). P. 1164–1171.
56. Moran A., Ben-Nun A., Potashnik R., Bashan N. Renal cells in culture as a model for cystinosis // Basic Clin. Physiol. Pharmacol. 1990. Vol. 1 (1–4). P. 357–372.
57. Nevo N, Chol M, Bailleux A. et al. Renal phenotype of the cystinosis mouse model is dependent upon genetic background // Nephrol. Dial. Transplant. 2010. Vol. 25 (4). P. 1059–1066.
58. Niaudet P. Mitochondrial disorders and the kidney // Arch. Dis. Child. 1998. Vol. 78 (4). P. 387–390.
59. Nilius B. Transient receptor potential (TRP) cation channels: rewarding unique proteins // Bull. Mem. Acad. R. Med. Belg. 2007. Vol. 162 (3–4). P. 244–253.
60. Njålsson R., Ristoff E., Carlsson K., Winkler A., Larsson A., Norgren S. Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency // Hum. Genet. 2005. Vol. 116 (5). P. 384–389.
61. Okamura D.M., Himmelfarb J. Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease // Pediatr. Nephrol. 2009. Vol. 24 (12). P. 2309–2319.
62. Patrick AD, Lake BD. Cystinosis: electron microscopic evidence of lysosomal storage of cystine in lymph node // J. Clin. Pathol. 1968. Vol. 21 (5). P. 571–575.
63. Pellett O.L., Smith M.L., Thoene J.G. et al. Renal cell culture using autopsy material from children with cystinosis // In Vitro. 1984. Vol. 20 (1). P. 53–58.
64. Peng J., Li Y.J. The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection // Eur. J. Pharmacol. 2010. Vol. 627 (1–3). P. 1–7.
65. Periyasamy-Thandavan S., Jiang M., Schoenlein P., Dong Z. Autophagy: molecular machinery, regulation, and implications for renal pathophysiology // Am. J. Physiol. Renal. Physiol. 2009. Vol. 297 (2). P. 244–256.
66. Pisoni R.L., Thoene J.G., Lemons R.M., Christensen H.N. Important differences in cationic amino acid transport by lysosomal system c and system y+ of the human fibroblast // J. Biol. Chem. 1987. Vol. 262 (31). P. 15011–15018.
67. Racusen L.C., Fivush B.A., Andersson H., Gahl W.A. Culture of renal tubular cells from the urine of patients with nephropathic cystinosis // J. Am. Soc. Nephrol. 1991. Vol. 1 (8). P. 1028–1033.
68. Racusen L.C., Wilson P.D., Hartz P.A. et al. Renal proximal tubular epithelium from patients with nephropathic cystinosis: immortalized cell lines as in vitro model systems // Kidney Int. 1995. Vol. 48 (2). P. 536–543.
69. Reeves J.P. Accumulation of amino acids by lysosomes incubated with amino acid methyl esters // J. Biol. Chem. 1979. Vol. 254 (18). P. 8914–8921.
70. Ristoff E., Larsson A. Inborn errors in the metabolism of glutathione // Orphanet J. Rare Dis. 2007. Vol. 2. P. 16.
71. Rizzo C., Ribes A., Pastore A. et al. Pyroglutamic aciduria and nephropathic cystinosis // J. Inherit Metab. Dis. 1999. Vol. 22 (3). P. 224–226.
72. Ryan M.J., Johnson G., Kirk J. et al. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney // Kidney Int. 1994. Vol. 45 (1). P. 48–57.
73. Saftig P., Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function // Nat. Rev. Mol. Cell. Biol. 2009. Vol. 10 (9). P. 623–635.
74. Salmon R.F., Baum M. Intracellular cystine loading inhibits transport in the rabbit proximal convoluted tubule // J. Clin. Invest. 1990. Vol. 85 (2). P. 340–344.
75. Sansanwal P., Kambham N., Sarwal M.M. Caspase-4 may play a role in loss of proximal tubules and renal injury in nephropathic cystinosis // Pediatr. Nephrol. 2010. Vol. 25 (1). P. 105–109.
76. Sansanwal P., Yen B., Gahl W.A. et al. Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis // J. Am. Soc. Nephrol. 2010. Vol. 21 (2). P. 272–283.
77. Santangelo F., Witko-Sarsat V., Drüeke T., Descamps-Latscha B. Restoring glutathione as a therapeutic strategy in chronic kidney disease // Nephrol. Dial. Transplant. 2004. Vol. 19 (8). P. 1951–1955.
78. Schneider J.A., Bradley K., Seegmiller J.E. Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis // Science. 1967. Vol. 157 (794). P. 1321–1322.
79. Schneider J.A., Rosenbloom F.M., Bradley K.H., Seegmiller J.E. Increased free-cystine content of fibroblasts cultured from patients with cystinosis // Biochem. Biophys. Res. Commun. 1967. Vol. 29 (4). P. 527–531.
80. Shah S.V., Baliga R., Rajapurkar M., Fonseca V.A. Oxidants in chronic kidney disease // J. Am. Soc. Nephrol. 2007. Vol. 18 (1). P. 16–28.
81. Steinherz R., Tietze F., Gahl W.A. et al. Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester // Proc. Natl. Acad. Sci. USA. 1982. Vol. 79 (14). P. 4446–4450.
82. Sutherland G.R., Bain A.D. Culture of cells from the urine of newborn children // Nature. 1972. Vol. 239 (5369). P. 231.
83. Syres K, Harrison F, Tadlock M. et al. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation // Blood. 2009. Vol. 114 (12). P. 2542–2552.
84. Taranta A., Wilmer M.J., van den Heuvel L.P. et al. Analysis of CTNS gene transcripts in nephropathic cystinosis // Pediatr. Nephrol. 2010. Vol. 25 (7). P. 1263–1267.
85. The Cystinosis Collaborative Research Group. Likage of the gene for cystinosis to markers on the short arm of chromosome 17 // Nat. Genet. 1995. Vol. 10. P. 246–248.
86. Thoene J.G., Lemons R. Modulation of the intracellular cystine content of cystinotic fibroblasts by extracellular albumin // Pediatr. Res. 1980. Vol. 14 (6). P. 785–787.
87. Thoene J.G., Oshima R.G., Crawhall J.C. et al. Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo // J. Clin. Invest. 1976. Vol. 58 (1). P. 180–189.
88. Touchman J.W., Anikster Y., Dietrich N.L. et al. The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion // Genome Res. 2000. Vol. 10 (2). P. 165–173.
89. Town M., Jean G., Cherqui S. et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis // Nat. Genet. 1998. Vol. 18 (4). P. 319–324.
90. Van Biervliet J.P., Bruinvis L., Ketting D. et al. Hereditary mitochondrial myopathy with lactic acidemia, a De Toni-Fanconi-Debré syndrome, and a defective respiratory chain in voluntary striated muscles // Pediatr. Res. 1977. Vol. 11 (10 Pt 2). P. 1088–1093.
91. Vitvitsky V., Witcher M., Banerjee R., Thoene J. The redox status of cystinotic fibroblasts // Mol. Genet. Metab. 2010. Vol. 99 (4). P. 384–388.
92. Wamelink M.M., Struys E.A., Jansen E.E. et al. Sedoheptulokinase deficiency due to a 57-kb deletion in cystinosis patients causes urinary accumulation of sedoheptulose: elucidation of the CARKL gene // Hum. Mutat. 2008. Vol. 29 (4). P. 532–536.
93. Wilmer M.J., Saleem M.A., Masereeuw R. et al. Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters // Cell. Tissue Res. 2010. Vol. 339 (2). P. 449–457.
94. Wilmer M.J., Willems P.H., Verkaart S. et al. Cystine dimethylester model of cystinosis: still reliable? // Pediatr. Res. 2007. Vol. 62 (2). P. 151–155.
95. Wilmer M.J., de Graaf-Hess A., Blom H.J. et al. Elevated oxidized glutathione in cystinotic proximal tubular epithelial cells // Biochem. Biophys. Res. Commun. 2005. Vol. 337 (2). P. 610–614.

Другие статьи по теме

• Нефротоксические эффекты высокоактивной антиретровирусной терапии (Обзор литературы)
• Диагноз инфантильной формы цистиноза: приговор или руководство к действию? (Обзор литературы и собственное наблюдение)
• Оценка переноса гомоцистеина белками и метаболические нарушения у пациентов, получающих лечение хроническим гемодиализом